Expression of ribonucleoside reductase subunit M1, but not excision repair cross-complementation group 1, is predictive in muscle-invasive bladder cancer treated with chemotherapy...

Por SHILKRUT, MARK, WU, ANGELA, THOMAS, DAFYDD G., HAMSTRA, DANIEL A.
Publicado em 2014

Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma

Por Xie, Hao, Lin, Jingmei, Thomas, Dafydd G, Jiang, Wei, Liu, Xiuli
Publicado em 2012

Stress-induced CXCR4 Promotes Migration and Invasion of Ewing Sarcoma

Por Krook, Melanie A., Nicholls, Lauren A., Scannell, Christopher A., Chugh, Rashmi, Thomas, Dafydd G., Lawlor, Elizabeth R.
Publicado em 2014

The Role of Dickkopf-3 Overexpression in Esophageal Adenocarcinoma

Por Wang, Zhuwen, Lin, Lin, Thomas, Dafydd G., Nadal, Ernest, Chang, Andrew C., Beer, David G., Lin, Jules
Publicado no J Thorac Cardiovasc Surg (2015)

Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma

Por Applebaum, Mark A., Thomas, Dafydd G., Hembrough, Todd, Burrows, Jon, Horvai, Andrew E., Lawlor, Elizabeth R., DuBois, Steven G.
Publicado em 2014

Paired Box Gene 8-Peroxisome Proliferator-Activated Receptor-γ Fusion Protein and Loss of Phosphatase and Tensin Homolog Synergistically Cause Thyroid Hyperplasia in Transgenic Mic...

Por Diallo-Krou, Ericka, Yu, Jingcheng, Colby, Lesley A., Inoki, Ken, Wilkinson, John E., Thomas, Dafydd G., Giordano, Thomas J., Koenig, Ronald J.
Publicado em 2009

Scavenging of CXCL12 by CXCR7 Promotes Tumor Growth and Metastasis of CXCR4-positive Breast Cancer Cells

Por Luker, Kathryn E., Lewin, Sarah A., Mihalko, Laura Anne, Schmidt, Bradley T., Winkler, Jessica S., Coggins, Nathaniel L., Thomas, Dafydd G., Luker, Gary D.
Publicado em 2012

Checkpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non–small cell lung cancer

Por Grabauskiene, Svetlana, Bergeron, Edward J., Chen, Guoan, Thomas, Dafydd G., Giordano, Thomas J., Beer, David G., Morgan, Meredith A., Reddy, Rishindra M.
Publicado em 2013

Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2

Por Choi, Yun-Jung, Ingram, Patrick N., Yang, Kun, Coffman, Lan, Iyengar, Mangala, Bai, Shoumei, Thomas, Dafydd G., Yoon, Euisik, Buckanovich, Ronald J.
Publicado no Proc Natl Acad Sci U S A (2015)

Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling

Por Giordano, Thomas J., Kuick, Rork, Else, Tobias, Gauger, Paul G., Vinco, Michelle, Bauersfeld, Juliane, Sanders, Donita, Thomas, Dafydd G., Doherty, Gerard, Hammer, Gary
Publicado em 2009

Utility of a Monoclonal ERG/FLI1 Antibody for Immunohistochemical Discrimination of Ewing’s Family Tumors

Por Tomlins, Scott A., Palanisamy, Nallasivam, Brenner, J. Chad, Stall, Jennifer N., Siddiqui, Javed, Thomas, Dafydd G., Lucas, David R., Chinnaiyan, Arul M., Kunju, Lakshmi P.
Publicado em 2013

Sporadic versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases

Por Hung, Jennifer, Hiniker, Susan M., Lucas, David R., Griffith, Kent A., McHugh, Jonathan B., Meirovitz, Amichay, Thomas, Dafydd G., Chugh, Rashmi, Herman, Joseph M.
Publicado em 2013

TGM2 A Cell Surface Marker in Esophageal Adenocarcinomas

Por Leicht, Deborah T., Kausar, Tasneem, Wang, Zhuwen, Ferrer-Torres, Daysha, Wang, Thomas D., Thomas, Dafydd G., Lin, Jules, Chang, Andrew C., Lin, Lin, Beer, David G.
Publicado em 2014

Preclinical Targeting of the Type I Insulin-Like Growth Factor Receptor in Adrenocortical Carcinoma

Por Barlaskar, Ferdous M., Spalding, Aaron C., Heaton, Joanne H., Kuick, Rork, Kim, Alex C., Thomas, Dafydd G., Giordano, Thomas J., Ben-Josef, Edgar, Hammer, Gary D.
Publicado em 2009

A Small-Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma

Por Shan, Weiwei, Akinfenwa, Patricia Y., Savannah, Kari B., Kolomeyevskaya, Nonna, Laucirica, Rudolfo, Thomas, Dafydd G., Odunsi, Kunle, Creighton, Chad J., Lev, Dina C., Anderson, Matthew L.
Publicado no Clin Cancer Res (2012)

l-Type Amino Acid Transporter-1 Overexpression and Melphalan Sensitivity in Barrett's Adenocarcinoma

Por Lin, Jules, Raoof, Duna A, Thomas, Dafydd G, Greenson, Joel K, Giordano, Thomas J, Robinson, Gregory S, Bourner, Maureen J, Bauer, Christopher T, Orringer, Mark B, Beer, David G
Publicado em 2004

Differential Protein Mapping of Ovarian Serous Adenocarcinomas: Identification of Potential Markers for Distinct Tumor Stage

Por Wang, Yanfei, Wu, Rong, Cho, Kathleen R., Thomas, Dafydd G., Gossner, Gabrielle, Liu, J. Rebecca, Giordano, Thomas J., Shedden, Kerby A., Misek, David E., Lubman, David M.
Publicado em 2009

Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas

Por Kim, Hyeyeung, Wu, Rong, Cho, Kathleen R., Thomas, Dafydd G., Gossner, Gabrielle, Liu, J. Rebecca, Giordano, Thomas J., Shedden, Kerby A., Misek, David E., Lubman, David M.
Publicado em 2008

CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cells

Por Grabauskiene, Svetlana, Bergeron, Edward J., Chen, Guoan, Chang, Andrew C., Lin, Jules, Thomas, Dafydd G., Giordano, Thomas J., Beer, David G., Morgan, Meredith A., Reddy, Rishindra M.
Publicado em 2013

Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis

Por Raskin, Leon, Fullen, Douglas R., Giordano, Thomas J., Thomas, Dafydd G., Frohm, Marcus L., Cha, Kelly B., Ahn, Jaeil, Mukherjee, Bhramar, Johnson, Timothy M., Gruber, Stephen B.
Publicado no J Invest Dermatol (2013)